Global Spatial Metabolomics Market Research Report 2024

Publication ID:

PB512240290

Publication Date:

December 24, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Spatial Metabolomics was valued at US$ 201 million in the year 2023 and is projected to reach a revised size of US$ 393 million by 2030, growing at a CAGR of 9.7% during the forecast period.
Spatial metabolomics is an innovative field that combines mass spectrometry imaging (MSI) with metabolomics to precisely analyze the species, concentrations, and spatial distributions of metabolites in biological tissues, organs, or even individual cells. This approach enhances the depth of metabolomic data, offering valuable insights into the molecular composition of biological systems within their spatial context, making it a powerful tool for advancing life sciences research.
North American market for Spatial Metabolomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Spatial Metabolomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Spatial Metabolomics in Plant and Agricultural Sciences is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Spatial Metabolomics include CD Genomics, Creative Dynamics Inc (Creative Proteomics), SciLifeLab, Metware Biotechnology Inc (Metware), APPLIED PROTEIN TECHNOLOGY, BGI Genomics, Suzhou PANOMIX Biomedical Tech Co.,Ltd, Novogene, OBiO Technology ( Shanghai ) Corp.,Ltd., Biotech Pack, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spatial Metabolomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spatial Metabolomics.
The Spatial Metabolomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spatial Metabolomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spatial Metabolomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Genomics
Creative Dynamics Inc (Creative Proteomics)
SciLifeLab
Metware Biotechnology Inc (Metware)
APPLIED PROTEIN TECHNOLOGY
BGI Genomics
Suzhou PANOMIX Biomedical Tech Co.,Ltd
Novogene
OBiO Technology ( Shanghai ) Corp.,Ltd.
Biotech Pack
Segment by Type
Plant Tissue
Human Tissue
Animal Tissue
Segment by Application
Plant and Agricultural Sciences
Food and Nutritional Sciences
Drug Development and Pharmacology
Cancer and Tumor Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spatial Metabolomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spatial Metabolomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plant Tissue
1.2.3 Human Tissue
1.2.4 Animal Tissue
1.3 Market by Application
1.3.1 Global Spatial Metabolomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Plant and Agricultural Sciences
1.3.3 Food and Nutritional Sciences
1.3.4 Drug Development and Pharmacology
1.3.5 Cancer and Tumor Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spatial Metabolomics Market Perspective (2019-2030)
2.2 Global Spatial Metabolomics Growth Trends by Region
2.2.1 Global Spatial Metabolomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Spatial Metabolomics Historic Market Size by Region (2019-2024)
2.2.3 Spatial Metabolomics Forecasted Market Size by Region (2025-2030)
2.3 Spatial Metabolomics Market Dynamics
2.3.1 Spatial Metabolomics Industry Trends
2.3.2 Spatial Metabolomics Market Drivers
2.3.3 Spatial Metabolomics Market Challenges
2.3.4 Spatial Metabolomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spatial Metabolomics Players by Revenue
3.1.1 Global Top Spatial Metabolomics Players by Revenue (2019-2024)
3.1.2 Global Spatial Metabolomics Revenue Market Share by Players (2019-2024)
3.2 Global Spatial Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spatial Metabolomics Revenue
3.4 Global Spatial Metabolomics Market Concentration Ratio
3.4.1 Global Spatial Metabolomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spatial Metabolomics Revenue in 2023
3.5 Global Key Players of Spatial Metabolomics Head office and Area Served
3.6 Global Key Players of Spatial Metabolomics, Product and Application
3.7 Global Key Players of Spatial Metabolomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spatial Metabolomics Breakdown Data by Type
4.1 Global Spatial Metabolomics Historic Market Size by Type (2019-2024)
4.2 Global Spatial Metabolomics Forecasted Market Size by Type (2025-2030)
5 Spatial Metabolomics Breakdown Data by Application
5.1 Global Spatial Metabolomics Historic Market Size by Application (2019-2024)
5.2 Global Spatial Metabolomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Spatial Metabolomics Market Size (2019-2030)
6.2 North America Spatial Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Spatial Metabolomics Market Size by Country (2019-2024)
6.4 North America Spatial Metabolomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spatial Metabolomics Market Size (2019-2030)
7.2 Europe Spatial Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Spatial Metabolomics Market Size by Country (2019-2024)
7.4 Europe Spatial Metabolomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spatial Metabolomics Market Size (2019-2030)
8.2 Asia-Pacific Spatial Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Spatial Metabolomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Spatial Metabolomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spatial Metabolomics Market Size (2019-2030)
9.2 Latin America Spatial Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Spatial Metabolomics Market Size by Country (2019-2024)
9.4 Latin America Spatial Metabolomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spatial Metabolomics Market Size (2019-2030)
10.2 Middle East & Africa Spatial Metabolomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Spatial Metabolomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Spatial Metabolomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Details
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Spatial Metabolomics Introduction
11.1.4 CD Genomics Revenue in Spatial Metabolomics Business (2019-2024)
11.1.5 CD Genomics Recent Development
11.2 Creative Dynamics Inc (Creative Proteomics)
11.2.1 Creative Dynamics Inc (Creative Proteomics) Company Details
11.2.2 Creative Dynamics Inc (Creative Proteomics) Business Overview
11.2.3 Creative Dynamics Inc (Creative Proteomics) Spatial Metabolomics Introduction
11.2.4 Creative Dynamics Inc (Creative Proteomics) Revenue in Spatial Metabolomics Business (2019-2024)
11.2.5 Creative Dynamics Inc (Creative Proteomics) Recent Development
11.3 SciLifeLab
11.3.1 SciLifeLab Company Details
11.3.2 SciLifeLab Business Overview
11.3.3 SciLifeLab Spatial Metabolomics Introduction
11.3.4 SciLifeLab Revenue in Spatial Metabolomics Business (2019-2024)
11.3.5 SciLifeLab Recent Development
11.4 Metware Biotechnology Inc (Metware)
11.4.1 Metware Biotechnology Inc (Metware) Company Details
11.4.2 Metware Biotechnology Inc (Metware) Business Overview
11.4.3 Metware Biotechnology Inc (Metware) Spatial Metabolomics Introduction
11.4.4 Metware Biotechnology Inc (Metware) Revenue in Spatial Metabolomics Business (2019-2024)
11.4.5 Metware Biotechnology Inc (Metware) Recent Development
11.5 APPLIED PROTEIN TECHNOLOGY
11.5.1 APPLIED PROTEIN TECHNOLOGY Company Details
11.5.2 APPLIED PROTEIN TECHNOLOGY Business Overview
11.5.3 APPLIED PROTEIN TECHNOLOGY Spatial Metabolomics Introduction
11.5.4 APPLIED PROTEIN TECHNOLOGY Revenue in Spatial Metabolomics Business (2019-2024)
11.5.5 APPLIED PROTEIN TECHNOLOGY Recent Development
11.6 BGI Genomics
11.6.1 BGI Genomics Company Details
11.6.2 BGI Genomics Business Overview
11.6.3 BGI Genomics Spatial Metabolomics Introduction
11.6.4 BGI Genomics Revenue in Spatial Metabolomics Business (2019-2024)
11.6.5 BGI Genomics Recent Development
11.7 Suzhou PANOMIX Biomedical Tech Co.,Ltd
11.7.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Details
11.7.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
11.7.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Spatial Metabolomics Introduction
11.7.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue in Spatial Metabolomics Business (2019-2024)
11.7.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Development
11.8 Novogene
11.8.1 Novogene Company Details
11.8.2 Novogene Business Overview
11.8.3 Novogene Spatial Metabolomics Introduction
11.8.4 Novogene Revenue in Spatial Metabolomics Business (2019-2024)
11.8.5 Novogene Recent Development
11.9 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.9.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.9.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.9.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Spatial Metabolomics Introduction
11.9.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Spatial Metabolomics Business (2019-2024)
11.9.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.10 Biotech Pack
11.10.1 Biotech Pack Company Details
11.10.2 Biotech Pack Business Overview
11.10.3 Biotech Pack Spatial Metabolomics Introduction
11.10.4 Biotech Pack Revenue in Spatial Metabolomics Business (2019-2024)
11.10.5 Biotech Pack Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

CD Genomics
Creative Dynamics Inc (Creative Proteomics)
SciLifeLab
Metware Biotechnology Inc (Metware)
APPLIED PROTEIN TECHNOLOGY
BGI Genomics
Suzhou PANOMIX Biomedical Tech Co.,Ltd
Novogene
OBiO Technology ( Shanghai ) Corp.,Ltd.
Biotech Pack

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂